1. cIAP1 has 618 amino acids according to GenBank no. and migrates at ~69kDaonSDS-PAGE.2. Observed molecular weights may vary as genes generally produce, by alternative splicing, multiple transcripts all with introns, putatively encoding multipledifferent protein isoforms. Additionally, proteins may undergo post translational modifications including phosphorylation, glycosylation and cleavage which can result in differential molecular weights. Protein modifications can vary between cell and tissue type, and proteins can migrate as one or multiple bands depending on the isoform expressed as well as post-translational modifications. Users are encourage to refer to the NCBI AceView. Use in Immunocytochemistry/immunofluorescence reported in scientific literature (PMID: 30054903).
Publications
Read Publications using NBP2-27190 in the following applications:
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Buffer
50 ul neat whole antisera
Preservative
0.05% Sodium Azide
Purity
Unpurified
Alternate Names for cIAP-1/HIAP-2 Antibody
API1Hiap-2
apoptosis inhibitor 1
baculoviral IAP repeat containing 2
baculoviral IAP repeat-containing 2
baculoviral IAP repeat-containing protein 2
BIRC2
cIAP1
c-IAP1
cIAP-1
hIAP2
HIAP-2
IAP homolog B
IAP2
IAP-2
Inhibitor of apoptosis protein 2
MIHB
MIHBHIAP2
NFR2-TRAF signalling complex protein
RING finger protein 48
RNF48hiap-2
TNFR2-TRAF-signaling complex protein 2
Background
cIAP1 (HIAP2, MIHB) is a member of the family of inhibitor of apoptosis proteins (IAP). IAPs suppress mitochondria-dependent and -independent apoptosis by binding to and inhibiting caspases through their BIR domains (reviewed in Liston et al, 2003; Wright and Duckett, 2005). Resistance towards apoptosis is a hallmark of cancer cells, and overexpression of IAPs can contribute to the development of cancer though inhibiting apoptosis. In addition to at least one BIR domain, some IAP members also have a RING-type finger motif at their carboxyl-terminal. The RING finger domain of several IAPs, including cIAP2, have E3 ubiquitin ligase activity and target the degradation of Smac/DIABLO through ubqiuitination. Smac/DIABLO is a death inducer and functions by inhibiting IAP-caspase interactions, thereby promoting apoptosis. Degradation of cell death inducers like Smac/DIABLO is thought to be a conserved mechanism by which IAPs enhance their anti-apoptotic activity, thereby promoting cell survival. The IAPs, including cIAP1, have widespread tissue protein expression, with expression levels and subcellular localization patterns differing depending on the cell lineage (see Vischioni et al. 2005 for a comprehensive study). IMG-5716 recognizes cIAP1, human cIAP1 is a 618 amino acid protein.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our cIAP-1/HIAP-2 Antibody and receive a gift card or discount.